SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-019481
Filing Date
2018-11-05
Accepted
2018-11-05 09:23:08
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20180930_10q.htm 10-Q 1099784
2 EXHIBIT 31.1 ex_126616.htm EX-31.1 9430
3 EXHIBIT 31.2 ex_126617.htm EX-31.2 9431
4 EXHIBIT 32.1 ex_126618.htm EX-32.1 7057
  Complete submission text file 0001437749-18-019481.txt   4268703

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acrx-20180930.xml EX-101.INS 844259
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20180930.xsd EX-101.SCH 49887
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20180930_cal.xml EX-101.CAL 34620
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20180930_def.xml EX-101.DEF 265169
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20180930_lab.xml EX-101.LAB 225231
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20180930_pre.xml EX-101.PRE 286800
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 181158971
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences